Solid forms of amlodipine besylate: Physicochemical, structural, and thermodynamic characterization

Crystal Growth and Design

Volumn 10, Issue 12, 2010, Pages 5279-5290

  Koradia, Vishal ^a   Lopez De Diego, Heidi ^b   Frydenvang, Karla ^a   Ringkjøbing Elema, Michiel ^b   Müllertz, Anette ^a   Bond, Andrew D ^c   Rantanen, Jukka ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b H LUNDBECK A S   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANHYDRATES; CALCIUM CHANNEL ANTAGONISTS; CORONARY ARTERY DISEASE; CRYSTAL STRUCTURE ANALYSIS; DIHYDRATES; HOFF ANALYSIS; HYDROGEN BOND NETWORKS; RANK ORDER; RAPID COOLING; SINGLE-CRYSTAL AND POWDER; SOLID FORMS; SOLUBILITY MEASUREMENT; STABLE FORM; STABLE PHASE; THERMODYNAMIC CHARACTERIZATION; WATER MOLECULE;

DEWATERING; DISEASES; HYDRATES; HYDROGEN; HYDROGEN BONDS; SOLUBILITY; SPECTROSCOPIC ANALYSIS; X RAY DIFFRACTION;

CRYSTAL STRUCTURE;

EID: 78649911465     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg101127z     Document Type: Article

References (55)

1. Hilfiker, R.; Blatter, F.; von Raumer, M. Relevance of solid-state properties for pharmaceutical products. In Polymorphism: In the Pharmaceutical Industry; Hilfiker, R., Ed.; WILEY-VCH Verlag GmbH & Co.: Weinheim, Germany, 2006; pp 1 - 19.
2. Gardner, C. R.; Walsh, C. T.; Almarsson, O. Drugs as materials: valuing physical form in drug discovery Nat. Rev. Drug. Discovery 2004, 3 (11) 926-934
3. Haleblian, J.; McCrone, W. Pharmaceutical applications of polymorphism J. Pharm. Sci. 1969, 58 (8) 911-929
4. Ali, A. A.; Farouk, A. Comparative studies on the bioavailability of ampicillin anhydrate and trihydrate Int. J. Pharm. 1981, 9 (3) 239-243
5. Singhal, D.; Curatolo, W. Drug polymorphism and dosage form design: a practical perspective Adv. Drug. Delivery Rev. 2004, 56 (3) 335-347
6. Viscomi, G. C.; Campana, M.; Barbanti, M.; Grepioni, F.; Polito, M.; Confortini, D.; Rosini, G.; Righi, P.; Cannata, V.; Braga, D. Crystal forms of rifaximin and their effect on pharmaceutical properties CrystEngComm 2008, 10 (8) 1074-1081
7. Wardrop, J.; Law, D.; Qiu, Y.; Engh, K.; Faitsch, L.; Ling, C. Influence of solid phase and formulation processing on stability of Abbott-232 tablet formulations J. Pharm. Sci. 2006, 95 (11) 2380-2392
8. Wikström, H.; Rantanen, J.; Gift, A. D.; Taylor, L. S. Toward an understanding of the factors influencing anhydrate-to-hydrate transformation kinetics in aqueous environments Cryst. Growth Des. 2008, 8 (8) 2684-2693
9. International Conference on Harmonization guidance Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products-chemical substances. U.S. Food and Drug Administration: Rockville, USA, 1999.
10. Guidance for industry. ANDAs: Pharmaceutical solid polymorphism. chemistry, manufacturing and controls information. U.S. Food and Drug Administration: Rockville, USA, 2007.
11. Griesser, U. J. The importance of solvates. In Polymorphism: In the Pharmaceutical Industry; Hilfiker, R., Ed. WILEY-VCH Verlag GmbH & Co.: Weinheim, Germany, 2006; pp 211 - 233.
12. Herbstein, F. H. Diversity amidst similarity: a multidisciplinary approach to phase relationships, solvates, and polymorphs Cryst. Growth Des. 2004, 4 (6) 1419-1429
13. Threlfall, T. L. Analysis of organic polymorphs a review Analyst 1995, 120 (10) 2435-2460
14. Cabri, W.; Ghetti, P.; Alpegiani, M.; Pozzi, G.; Justo-Erbez, A.; Perez-Martinez, J. I.; Villalon-Rubio, R.; Monedero-Perales, M. C.; Munoz-Ruiz, A. Cefdinir: a comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour Eur. J. Pharm. Biopharm. 2006, 64 (2) 212-221
15. Reutzel-Edens, S. M.; Bush, J. K.; Magee, P. A.; Stephenson, G. A.; Byrn, S. R. Anhydrates and hydrates of olanzapine: crystallization, solid-state characterization, and structural relationships Cryst. Growth Des. 2003, 3 (6) 897-907
16. Galwey, A. K. Structure and order in thermal dehydrations of crystalline solids Thermochim. Acta 2000, 355 (1-2) 181-238
17. Petit, S.; Coquerel, G. Mechanism of several solid-solid transformations between dihydrated and anhydrous copper(II) 8-hydroxyquinolinates. Proposition for a unified model for the dehydration of molecular crystals Chem. Mater. 1996, 8 (9) 2247-2258
18. Epstein, B. J.; Vogel, K.; Palmer, B. F. Dihydropyridine calcium channel antagonists in the management of hypertension Drugs 2007, 67 (9) 1309-1327
19. Caron, G.; Ermondi, G.; Damiano, A.; Novaroli, L.; Tsinman, O.; Ruell, J. A.; Avdeef, A. Ionization, lipophilicity, and molecular modeling to investigate permeability and other biological properties of amlodipine Bioorg. Med. Chem. 2004, 12 (23) 6107-6118
20. Kasim, N. A.; Whitehouse, M.; Ramachandran, C.; Bermejo, M.; Lennernas, H.; Hussain, A. S.; Junginger, H. E.; Stavchansky, S. A.; Midha, K. K.; Shah, V. P.; Amidon, G. L. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification Mol. Pharmaceutics 2004, 1 (1) 85-96
21. Rollinger, J.; Burger, A. Physico-chemical characterization of hydrated and anhydrous crystal forms of amlodipine besylate J. Therm. Anal. Calorim. 2002, 68 (2) 361-372
22. Ettema, G. J. B.; Hoorn, H.; Lemmens, J. M. Amlodipine salt forms and processes for preparing them. US6828339B2, 2004.
23. Mereiter, K.; Rollinger, J., Private Communication to the CCDC: deposition no. 190882, 2002.
24. COLLECT, Data Collection Software; Nonius BV: Delft, The Netherlands, 1999.
25. Duisenberg, A. J. M. Indexing in single-crystal diffractometry with an obstinate list of reflections J. Appl. Crystallogr. 1992, 25, 92-96
26. Duisenberg, A. J. M. EvalCCD. Reflections on area detectors: ab inito calculation of single-crystal x-ray reflection contours. University of Utrecht, Utrecht, The Netherlands, 1998.
27. Coppens, P. In Crystallographic Computing; Ahmed, F. R.; Hall, S. R.; Huber, C. P., Eds.; Munksgaard: Copenhagen, Denmark, 1970; pp 255 - 270.
28. Mackay, S.; Gilmore, C. J.; Edwards, C.; Stewart, N.; Shankland, K. maXus: Computer Program for the Solution and Refinement of Crystal Structures; Bruker Nonius: The Netherlands, 1999.
29. Sheldrick, G. M. A short history of SHELX Acta Crystallogr., Sect. A 2008, 64, 112-122
30. Wilson, A. J. C. International Tables for Crystallography Vol. C. In Kluwer Academic Publishers: Dordrecht, The Netherlands, 1992; Tables 4.2.6.8 and 6.1.1.4.
31. Bond, A. D. Why do crystal structures waste molecular inversion symmetry? CrystEngComm 2010, 12 (8) 2492-2500
32. Li, Y. H.; Han, J.; Zhang, G. G. Z.; Grant, D. J. W.; Suryanarayanan, R. In situ dehydration of carbamazepine dihydrate: A novel technique to prepare amorphous anhydrous carbamazepine Pharm. Dev. Technol. 2000, 5 (2) 257-266
33. Ding, S. P.; Fan, J.; Green, J. L.; Lu, Q.; Sanchez, E.; Angell, C. A. Vitrification of trehalose by water loss from its crystalline dihydrate J. Therm. Anal. Calorim. 1996, 47 (5) 1391-1405
34. Taylor, L. S.; York, P. Characterization of the phase transitions of trehalose dihydrate on heating and subsequent dehydration J. Pharm. Sci. 1998, 87 (3) 347-355
35. Taylor, L. S.; Williams, A. C.; York, P. Particle size dependent molecular rearrangements during the dehydration of trehalose dihydrate-in situ FT-Raman spectroscopy Pharm. Res. 1998, 15 (8) 1207-1214
36. Zimmermann, A.; Tian, F.; De Diego, H. L.; Frydenvang, K.; Rantanen, J.; Elema, M. R.; Hovgaard, L. Structural characterisation and dehydration behaviour of siramesine hydrochloride J. Pharm. Sci. 2009, 98 (10) 3596-3607
37. Miroshnyk, I.; Khriachtchev, L.; Mirza, S.; Rantanen, J.; Heinamaki, J.; Yliruusi, J. Insight into thermally induced phase transformations of erythromycin A dihydrate Cryst. Growth Des. 2006, 6 (2) 369-374
38. Kawashima, Y.; Niwa, T.; Takeuchi, H.; Hino, T.; Itoh, Y.; Furuyama, S. Characterization of polymorphs of tranilast anhydrate and tranilast monohydrate when crystallized by 2 solvent change spherical crystallization techniques J. Pharm. Sci. 1991, 80 (5) 472-478
39. Sheng, J.; Venkatesh, G. M.; Duddu, S. P.; Grant, D. J. Dehydration behavior of eprosartan mesylate dihydrate J. Pharm. Sci. 1999, 88 (10) 1021-1029
40. Jørgensen, A. C.; Strachan, C. J.; Pollanen, K. H.; Koradia, V.; Tian, F.; Rantanen, J. An insight into water of crystallization during processing using vibrational spectroscopy J. Pharm. Sci. 2009, 98 (11) 3903-3932
41. Nakamoto, K.; Margoshes, M.; Rundle, R. E. Stretching frequencies as a function of distances in hydrogen bonds J. Am. Chem. Soc. 1955, 77 (24) 6480-6486
42. Tang, X. C.; Pikal, M. J.; Taylor, L. S. A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers Pharm. Res. 2002, 19 (4) 477-483
43. Smith, E.; Dent, G., The theory of Raman spectroscopy. In Modern Raman Spectroscopy: A Practical Approach; Chichester, UK, 2005; pp 71 - 92.
44. Chan, K. L. A.; Fleming, O. S.; Kazarian, S. G.; Vassou, D.; Chryssikos, G. D.; Gionis, V. Polymorphism and devitrification of nifedipine under controlled humidity: a combined FT-Raman, IR and Raman microscopic investigation J. Raman Spectrosc. 2004, 35 (5) 353-359
45. Pudipeddi, M.; Serajuddin, A. T. Trends in solubility of polymorphs J. Pharm. Sci. 2005, 94 (5) 929-939
46. Zimmermann, A.; Tian, F.; de Diego, H. L.; Elema, M. R.; Rantanen, J.; Mullertz, A.; Hovgaard, L. Influence of the solid form of siramesine hydrochloride on its behavior in aqueous environments Pharm. Res. 2009, 26 (4) 846-854
47. Tong, H. H. Y.; Chow, A. S. F.; Chan, H. M.; Chow, A. H. L.; Wan, Y. K. Y.; Williams, I. D.; Shek, F. L. Y.; Chan, C. K. Process-induced phase transformation of berberine chloride hydrates J. Pharm. Sci. 2010, 99 (4) 1942-1954
48. Reutzel-Edens, S. M.; Kleemann, R. L.; Lewellen, P. L.; Borghese, A. L.; Antoine, L. J. Crystal forms of LY334370 HCl: Isolation, solid-state characterization, and physicochemical properties J. Pharm. Sci. 2003, 92 (6) 1196-1205
49. Khankari, R. K.; Grant, D. J. W. Pharmaceutical hydrates Thermochim. Acta 1995, 248, 61-79
50. Cardew, P. T.; Davey, R. J. The kinetics of solvent-mediated phase transformations Proc. R. Soc. Lond. A 1985, 398 (1815) 415-428
51. Young, S. W.; Burke, W. E. On the composition and solubility of the hydrates of sodium thiosulphate J. Am. Chem. Soc. 1904, 26 (11) 1413-1422
52. Chattaway, F. D.; Lambert, W. J. The transition points of the polymorphic phthalylhydrazides J. Am. Chem. Soc. 1915, 107, 1773-1797
53. Aaltonen, J.; Alleso, M.; Mirza, S.; Koradia, V.; Gordon, K. C.; Rantanen, J. Solid form screening-a review Eur. J. Pharm. Biopharm. 2009, 71 (1) 23-37
54. Mullin, J. W. Nucleation. In Crystallization; Elsevier Butterworth-Heinemann: Oxford, UK, 2001; pp 181 - 215.
55. Allesø, M.; Tian, F.; Cornett, C.; Rantanen, J. Towards effective solid form screening J. Pharm. Sci. 2010, 99 (9) 3711-3718